What is the catalog number for B3GNT8 Rabbit Polyclonal Antibody?

The catalog number for B3GNT8 Rabbit Polyclonal Antibody is orb316549.

What sizes are available for B3GNT8 Rabbit Polyclonal Antibody?

B3GNT8 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is B3GNT8 Rabbit Polyclonal Antibody in stock?

B3GNT8 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

B3GNT8 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase 8; BGnT-8; Beta-1, 3-Gn-T8; Beta-1, 3-N-acetylglucosaminyltransferase 8; Beta3Gn-T8; 2.4.1.-; B3GNT8; B3GALT7, BGALT15

UniProt

Q7Z7M8

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human B3GNT8, different from the related mouse sequence by sixteen amino acids.

Target

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Disease Biomarkers, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

43 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.